Egyptian International Pharmaceutical Industries Company announces an Equity Buyback for 1.61% of its issued share capital.

Egyptian International Pharmaceutical Industries Company (CASE:PHAR) announces a share repurchase program. Under the program, the company will repurchase up to 1.61% of treasury shares.